STOUT JAY S (Chief Technology Officer) sold 0.6% of their position (1.20K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $31.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/9/2026ACC: 0001764013-26-000002
Officer· Chief Technology Officer
Since Apr 2023
-1.20K
Net shares
Net seller
$31.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.15K
Price / share
$26.51
Trade value
$30.43K
% of position
0.6%
1/7/2026
200.81K→199.67K
Common Stock
Direct
Shares
−55.00
Price / share
$26.92
Trade value
$1.48K
% of position
0.0%
1/7/2026
199.67K→199.61K
Total
Net shares
−1.20K
Net value
-$31.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2026 | S · Sale | −1.15K | $26.51 | $30.43K | 0.6% | 200.81K | 199.67K |
| Common Stock Direct | 1/7/2026 | S · Sale | −55.00 | $26.92 | $1.48K | 0.0% | 199.67K | 199.61K |
| Total | −1.20K | -$31.91K | ||||||
Derivative Transactions0
No derivative transactions reported